SEI Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$80.3M Sell
287,912
-4,002
-1% -$1.15M 0.07% 288
2025
Q4
$88.4M Buy
291,914
+9,445
+3% +$2.95M 0.09% 239
2025
Q3
$79.2M Buy
282,469
+17,084
+6% +$4.65M 0.09% 230
2025
Q2
$64M Buy
265,385
+11,823
+5% +$2.79M 0.07% 283
2025
Q1
$61.8M Sell
253,562
-17,825
-7% -$5.36M 0.08% 279
2024
Q4
$89.2M Buy
271,387
+18,873
+7% +$6.41M 0.11% 179
2024
Q3
$84.5M Buy
252,514
+12,353
+5% +$3.92M 0.11% 195
2024
Q2
$65.6M Buy
240,161
+53,535
+29% +$15.6M 0.09% 232
2024
Q1
$64.5M Buy
186,626
+29,360
+19% +$9.65M 0.09% 227
2023
Q4
$50.8M Buy
157,266
+15,094
+11% +$4.73M 0.08% 268
2023
Q3
$51M Buy
142,172
+14,972
+12% +$5.78M 0.09% 217
2023
Q2
$48.2M Sell
127,200
-5,601
-4% -$2.28M 0.08% 238
2023
Q1
$63.6M Buy
132,801
+24,667
+23% +$11.5M 0.12% 169
2022
Q4
$45.5M Sell
108,134
-18,590
-15% -$7.5M 0.1% 210
2022
Q3
$52.9M Buy
126,724
+6,103
+5% +$3.04M 0.12% 165
2022
Q2
$59.7M Buy
120,621
+32,420
+37% +$16.9M 0.13% 142
2022
Q1
$49.9M Buy
88,201
+5,867
+7% +$3.54M 0.1% 199
2021
Q4
$62.3M Sell
82,334
-2,018
-2% -$1.51M 0.12% 181
2021
Q3
$62.8M Buy
84,352
+67,172
+391% +$50.3M 0.13% 159
2021
Q2
$11.1M Buy
17,180
+781
+5% +$475K 0.02% 670
2021
Q1
$9.41M Buy
16,399
+3,283
+25% +$1.94M 0.02% 704
2020
Q4
$7.66M Buy
13,116
+809
+7% +$461K 0.02% 767
2020
Q3
$6.71M Sell
12,307
-5,374
-30% -$2.72M 0.02% 732
2020
Q2
$7.83M Buy
17,681
+510
+3% +$225K 0.02% 663
2020
Q1
$5.96M Buy
17,171
+2,699
+19% +$992K 0.02% 677
2019
Q4
$5.27M Sell
14,472
-8,367
-37% -$2.95M 0.02% 895
2019
Q3
$7.6M Buy
22,839
+5,259
+30% +$1.72M 0.02% 724
2019
Q2
$5.6M Sell
17,580
-599
-3% -$179K 0.02% 881
2019
Q1
$5.65M Sell
18,179
-19,323
-52% -$5.21M 0.02% 846
2018
Q4
$10.6M Buy
37,502
+5,410
+17% +$1.45M 0.04% 525
2018
Q3
$10.1M Sell
32,092
-28,279
-47% -$8.78M 0.04% 513
2018
Q2
$17.4M Buy
+60,371
New +$16.7M 0.06% 346
2018
Q1
Sell
-93,387
Closed -$21.9M 3470
2017
Q4
$21.9M Buy
93,387
+17,890
+24% +$4.34M 0.08% 290
2017
Q3
$16.4M Buy
75,497
+18,629
+33% +$4.19M 0.06% 384
2017
Q2
$12.9M Buy
56,868
+9,106
+19% +$1.98M 0.05% 446
2017
Q1
$9.52M Sell
47,762
-925
-2% -$178K 0.04% 533
2016
Q4
$8.83M Buy
48,687
+26,418
+119% +$4.5M 0.04% 533
2016
Q3
$3.65M Buy
22,269
+1,113
+5% +$169K 0.02% 839
2016
Q2
$3.03M Buy
21,156
+1,484
+8% +$212K 0.02% 841
2016
Q1
$2.69M Buy
19,672
+573
+3% +$75.2K 0.02% 851
2015
Q4
$2.65M Buy
19,099
+642
+3% +$89K 0.02% 896
2015
Q3
$2.48M Sell
18,457
-4,003
-18% -$576K 0.02% 706
2015
Q2
$3.38M Sell
22,460
-578
-3% -$82.7K 0.03% 580
2015
Q1
$3.12M Buy
23,038
+177
+0.8% +$21.9K 0.03% 591
2014
Q4
$2.76M Buy
+22,861
New +$2.63M 0.02% 592

Other funds holding BIO